Article: Care Delivery
Patient satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy in women with diabetes
Article first published online: 11 JAN 2012
© 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK
Volume 29, Issue 2, pages 272–277, February 2012
How to Cite
Secher, A. L., Madsen, A. B., Ringholm, L., Barfred, C., Stage, E., Andersen, H. U., Damm, P. and Mathiesen, E. R. (2012), Patient satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy in women with diabetes. Diabetic Medicine, 29: 272–277. doi: 10.1111/j.1464-5491.2011.03426.x
- Issue published online: 11 JAN 2012
- Article first published online: 11 JAN 2012
- Accepted manuscript online: 26 AUG 2011 09:39PM EST
- Accepted 19 August 2011
- continuous glucose monitoring;
- early pregnancy;
- patient satisfaction;
- pregestational diabetes
Diabet. Med. 29, 272–277 (2012)
Aim To evaluate self-reported satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy among women with pregestational diabetes.
Methods Fifty-four women with Type 1 diabetes and 14 women with Type 2 diabetes were offered continuous glucose monitoring for 6 days at median 9 (range 6–14) gestational weeks and were asked to answer a semi-structured questionnaire on patient satisfaction.
Results Median HbA1c was 49 (range 34–86) mmol/mol) [6.6 (5.3–10.0) %] and duration of diabetes was 12 (0.5–37) years. Continuous glucose monitoring was used for 6 (0.5–7) days, with 43 (65%) women using continuous glucose monitoring for at least 5 days. The women experienced 2.7 (0–12) alarms per 24 h, of which approximately one third was technical alarms and one third disturbed their sleep. Sixteen women (24%) reported discomfort with continuous glucose monitoring during daytime and twelve (18%) during sleep. Many women reported improved diabetes understanding (52%) and would recommend continuous glucose monitoring to others (83%). Twenty-four patients (36%) had continuous glucose monitoring removed earlier than planned ( before the intended 6 days of initial monitoring). Ten women (15%) did not wish to use continuous glucose monitoring again in pregnancy. Main causes behind early removal of continuous glucose monitoring were self-reported skin irritation, technical problems and continuous glucose monitoring inaccuracy. No differences were found in continuous glucose monitoring use, inconvenience or compliance with respect to diabetes type.
Conclusions The majority of pregnant women with diabetes found real-time continuous glucose monitoring useful and the intervention was equally tolerated regardless of diabetes type. Nevertheless, continuous glucose monitoring was frequently removed earlier than planned, primarily because of skin irritation, technical problems and inaccuracy.